MORRISVILLE, N.C. , March 01, 2021 (GLOBE NEWSWIRE) -- Syneos Health, Inc. (Nasdaq: SYNH) (the “Company” or “Syneos Health”), the only fully integrated biopharmaceutical solutions organization combining a CRO (Contract Research Organization) and a CCO ( Contract Commercial Organization ), today
MORRISVILLE, N.C. , March 01, 2021 (GLOBE NEWSWIRE) -- Syneos Health, Inc. (Nasdaq: SYNH) (the “Company” or “Syneos Health”), the only fully integrated biopharmaceutical solutions organization combining a CRO (Contract Research Organization) and a CCO ( Contract Commercial Organization ), today
Strategic Partnership Optimizes Integration for EHR Data and Delivers Remote Source Data Review MORRISVILLE, N.C. and SALT LAKE CITY , Feb. 24, 2021 (GLOBE NEWSWIRE) -- Syneos Health ® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, and Protocol First, Inc.
Seasoned Talent to Drive Expansion of Solutions at the Intersection of Value and Policy MORRISVILLE, N.C. , Feb. 23, 2021 (GLOBE NEWSWIRE) -- Syneos Health Communications – the portfolio of Syneos Health ® agencies designed to deliver insights-driven integrated communications spanning advertising,
Highlights GAAP revenue of $1,140.0 million for the three months ended December 31, 2020 , representing a sequential increase of 3.7% compared to the three months ended September 30, 2020 . Net new business awards of $1,764.1 million and $5,863.1 million for the three and twelve months ended
Shared Commitment to Change, New Prescriber Realities, Model Evolution and Engagement Transformation Expected to be Critical Drivers MORRISVILLE, N.C. , Feb. 11, 2021 (GLOBE NEWSWIRE) -- Syneos Health ® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, is pulsing a
MORRISVILLE, N.C. , Jan. 26, 2021 (GLOBE NEWSWIRE) -- Syneos Health ® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, will release its fourth quarter and full year 2020 financial results on Thursday, February 18, 2021 , prior to its earnings call at 8:00 a.m. ET .
MORRISVILLE, N.C. , Jan. 04, 2021 (GLOBE NEWSWIRE) -- Syneos Health ® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization combining a CRO (Contract Research Organization) and a CCO ( Contract Commercial Organization ), today announced that Chief Executive Officer
